Filter search criteria using below inputs
Click on magnifying glass icon to search
Company | Country | Symbol |
---|
Time | Volume | RPRX |
---|---|---|
09:32 ET | 21272 | 28.355 |
09:34 ET | 3166 | 28.36 |
09:36 ET | 5579 | 28.29 |
09:38 ET | 2050 | 28.27 |
09:39 ET | 5291 | 28.25 |
09:41 ET | 3333 | 28.26 |
09:43 ET | 3292 | 28.3 |
09:45 ET | 7326 | 28.31 |
09:48 ET | 6052 | 28.3 |
09:50 ET | 3083 | 28.285 |
09:52 ET | 2673 | 28.285 |
09:54 ET | 7377 | 28.275 |
09:56 ET | 8466 | 28.28 |
09:57 ET | 2372 | 28.29 |
09:59 ET | 5191 | 28.35 |
10:01 ET | 5372 | 28.37 |
10:03 ET | 4454 | 28.295 |
10:06 ET | 9396 | 28.3 |
10:08 ET | 4028 | 28.325 |
10:10 ET | 4539 | 28.295 |
10:12 ET | 9772 | 28.325 |
10:14 ET | 5257 | 28.33 |
10:15 ET | 3034 | 28.345 |
10:17 ET | 10755 | 28.35 |
10:19 ET | 5230 | 28.335 |
10:21 ET | 4409 | 28.35 |
10:24 ET | 1943 | 28.36 |
10:26 ET | 2939 | 28.39 |
10:28 ET | 5513 | 28.41 |
10:30 ET | 5731 | 28.39 |
10:32 ET | 3763 | 28.38 |
10:33 ET | 11564 | 28.31 |
10:35 ET | 3757 | 28.345 |
10:37 ET | 2111 | 28.36 |
10:39 ET | 5291 | 28.375 |
10:42 ET | 1265 | 28.375 |
10:44 ET | 3686 | 28.375 |
10:46 ET | 1289 | 28.3711 |
10:48 ET | 3975 | 28.385 |
10:50 ET | 3329 | 28.395 |
10:51 ET | 3763 | 28.405 |
10:53 ET | 4540 | 28.395 |
10:55 ET | 4952 | 28.38 |
10:57 ET | 948 | 28.385 |
11:00 ET | 3338 | 28.4 |
11:02 ET | 3225 | 28.395 |
11:04 ET | 3230 | 28.4039 |
11:06 ET | 6703 | 28.405 |
11:08 ET | 1265 | 28.415 |
11:09 ET | 2793 | 28.405 |
11:11 ET | 1408 | 28.415 |
11:13 ET | 3737 | 28.435 |
11:15 ET | 1527 | 28.445 |
11:18 ET | 5515 | 28.48 |
11:20 ET | 6214 | 28.485 |
11:22 ET | 450 | 28.49 |
11:24 ET | 3925 | 28.49 |
11:26 ET | 2094 | 28.49 |
11:27 ET | 2969 | 28.47 |
11:29 ET | 2270 | 28.465 |
11:31 ET | 1009 | 28.465 |
11:33 ET | 2200 | 28.465 |
11:36 ET | 6066 | 28.465 |
11:38 ET | 1216 | 28.465 |
11:40 ET | 1966 | 28.445 |
11:42 ET | 1846 | 28.44 |
11:44 ET | 3124 | 28.405 |
11:45 ET | 37741 | 28.475 |
11:47 ET | 2700 | 28.4651 |
11:49 ET | 4108 | 28.47 |
11:51 ET | 1150 | 28.47 |
11:54 ET | 3037 | 28.48 |
11:56 ET | 1885 | 28.475 |
11:58 ET | 7545 | 28.455 |
12:00 ET | 2962 | 28.445 |
12:02 ET | 974 | 28.445 |
12:03 ET | 3405 | 28.435 |
12:05 ET | 1248 | 28.445 |
12:07 ET | 1196 | 28.445 |
12:09 ET | 502 | 28.445 |
12:12 ET | 4120 | 28.435 |
12:14 ET | 2080 | 28.435 |
12:16 ET | 5565 | 28.415 |
12:18 ET | 1417 | 28.415 |
12:20 ET | 7488 | 28.405 |
12:21 ET | 1640 | 28.415 |
12:23 ET | 2234 | 28.415 |
12:25 ET | 5013 | 28.405 |
12:27 ET | 2778 | 28.405 |
12:30 ET | 694 | 28.41 |
12:32 ET | 2550 | 28.405 |
12:34 ET | 8940 | 28.365 |
12:36 ET | 2286 | 28.345 |
12:38 ET | 600 | 28.345 |
12:39 ET | 6981 | 28.345 |
12:41 ET | 1401 | 28.355 |
12:43 ET | 714 | 28.355 |
12:45 ET | 2867 | 28.355 |
12:48 ET | 6004 | 28.335 |
12:50 ET | 2113 | 28.325 |
12:52 ET | 1039 | 28.325 |
12:54 ET | 4846 | 28.31 |
12:56 ET | 2851 | 28.315 |
12:57 ET | 646 | 28.315 |
12:59 ET | 2851 | 28.29 |
01:01 ET | 1825 | 28.285 |
01:03 ET | 1615 | 28.285 |
01:06 ET | 1461 | 28.285 |
01:08 ET | 3714 | 28.275 |
01:10 ET | 2606 | 28.265 |
01:12 ET | 4063 | 28.285 |
01:14 ET | 649 | 28.285 |
01:15 ET | 943 | 28.285 |
01:17 ET | 1737 | 28.285 |
01:19 ET | 5367 | 28.3 |
01:21 ET | 4359 | 28.305 |
01:24 ET | 2926 | 28.305 |
01:26 ET | 1121 | 28.305 |
01:28 ET | 4920 | 28.295 |
01:30 ET | 2351 | 28.315 |
01:32 ET | 1456 | 28.335 |
01:33 ET | 4783 | 28.315 |
01:35 ET | 2434 | 28.325 |
01:37 ET | 2389 | 28.335 |
01:39 ET | 926 | 28.335 |
01:42 ET | 3067 | 28.335 |
01:44 ET | 1355 | 28.33 |
01:46 ET | 1695 | 28.335 |
01:48 ET | 4202 | 28.345 |
01:50 ET | 3007 | 28.37 |
01:51 ET | 2792 | 28.365 |
01:53 ET | 7066 | 28.35 |
01:55 ET | 1712 | 28.365 |
01:57 ET | 3521 | 28.325 |
02:00 ET | 1604 | 28.325 |
02:02 ET | 2324 | 28.33 |
02:04 ET | 3597 | 28.305 |
02:06 ET | 5086 | 28.285 |
02:08 ET | 986 | 28.285 |
02:09 ET | 1619 | 28.285 |
02:11 ET | 3012 | 28.295 |
02:13 ET | 3267 | 28.305 |
02:15 ET | 1339 | 28.305 |
02:18 ET | 1382 | 28.305 |
02:20 ET | 1313 | 28.305 |
02:22 ET | 2839 | 28.315 |
02:24 ET | 6862 | 28.305 |
02:26 ET | 4968 | 28.295 |
02:27 ET | 2979 | 28.28 |
02:29 ET | 2941 | 28.295 |
02:31 ET | 3441 | 28.29 |
02:33 ET | 7157 | 28.285 |
02:36 ET | 2031 | 28.295 |
02:38 ET | 2493 | 28.29 |
02:40 ET | 8291 | 28.285 |
02:42 ET | 6075 | 28.285 |
02:44 ET | 1607 | 28.28 |
02:45 ET | 1996 | 28.285 |
02:47 ET | 1758 | 28.295 |
02:49 ET | 5792 | 28.28 |
02:51 ET | 3380 | 28.29 |
02:54 ET | 5628 | 28.285 |
02:56 ET | 3914 | 28.315 |
02:58 ET | 3000 | 28.335 |
03:00 ET | 5461 | 28.355 |
03:02 ET | 1058 | 28.37 |
03:03 ET | 6126 | 28.35 |
03:05 ET | 3042 | 28.355 |
03:07 ET | 3544 | 28.35 |
03:09 ET | 1188 | 28.345 |
03:12 ET | 1500 | 28.345 |
03:14 ET | 8924 | 28.315 |
03:16 ET | 1600 | 28.315 |
03:18 ET | 3474 | 28.315 |
03:20 ET | 8018 | 28.31 |
03:21 ET | 3846 | 28.295 |
03:23 ET | 1630 | 28.295 |
03:25 ET | 6538 | 28.295 |
03:27 ET | 7736 | 28.295 |
03:30 ET | 2928 | 28.305 |
03:32 ET | 16869 | 28.285 |
03:34 ET | 13150 | 28.255 |
03:36 ET | 2700 | 28.2587 |
03:38 ET | 13278 | 28.265 |
03:39 ET | 4823 | 28.265 |
03:41 ET | 5124 | 28.255 |
03:43 ET | 6163 | 28.245 |
03:45 ET | 10722 | 28.22 |
03:48 ET | 19492 | 28.245 |
03:50 ET | 10552 | 28.225 |
03:52 ET | 17829 | 28.225 |
03:54 ET | 17837 | 28.225 |
03:56 ET | 31879 | 28.225 |
03:57 ET | 17590 | 28.21 |
03:59 ET | 409565 | 28.21 |
Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
---|---|---|---|
Royalty Pharma PLC | 16.6B | 18.8x | +1.83% |
Amneal Pharmaceuticals Inc | 2.7B | -13.2x | --- |
Endo Inc | 2.0B | 0.4x | --- |
Catalent Inc | 10.9B | -10.5x | --- |
Jazz Pharmaceuticals PLC | 6.7B | 19.1x | -3.53% |
Mallinckrodt PLC | 1.6M | 0.0x | --- |
Royalty Pharma plc is a buyer of biopharmaceutical royalties and a funder of innovation across the biopharmaceutical industry. The Company collaborates with innovators from academic institutions, research hospitals and non-profits through small and mid-cap biotechnology companies to global pharmaceutical companies. Its portfolio consists of royalties on over 35 commercial products, including Vertex’s Trikafta, GSK’s Trelegy, Roche’s Evrysdi, Johnson & Johnson’s Tremfya, Biogen’s Tysabri and Spinraza, AbbVie and Johnson & Johnson’s Imbruvica, Astellas and Pfizer’s Xtandi, Novartis’ Promacta, Pfizer’s Nurtec ODT and Gilead’s Trodelvy, and 14 development-stage product candidates. Its development-stage product candidates include Aficamten, Ampreloxetine, BCX10013, MK-8189, Ecopipam, Olpasiran, Pelabresib, KarXT, Pelacarsen, Seltorexant, Trontinemab, TEV-'749, Tulmimetostat and Vanzacaftor. Its subsidiaries include Royalty Pharma Holdings Ltd., Royalty Pharma Investments and others.
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $16.6B |
---|---|
Revenue (TTM) | $2.2B |
Shares Outstanding | 597.4M |
Dividend Yield | 2.98% |
Annual Dividend Rate | 0.8400 USD |
Ex-Dividend Date | 08-16-24 |
Pay Date | 09-13-24 |
Beta | 0.46 |
EPS | $1.50 |
Book Value | $14.61 |
P/E Ratio | 18.8x |
Price/Sales (TTM) | 7.4 |
Price/Cash Flow (TTM) | 19.7x |
Operating Margin | 42.91% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.